• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Research & Markets: Novartis Pharma AG, Pfizer Inc.& Schering-Plough Corporation Are Just Some of the Leading Companies Operating in the Asthma Therapeutics Market

Posted on: Wednesday, 29 November 2006, 15:02 CST

Research and Markets (http://www.researchandmarkets.com/reports/c46170 ) has announced the addition of Asthma Therapeutics - Global Strategic Business Report to their offering.

This report analyzes the worldwide markets for Asthma Therapeutics in US$ Million. The major therapeutic segments analyzed are Inhaled corticosteroids, Short acting beta agonists, Long acting beta agonists, Combinations, and Anti- leukotrienes. The report provides separate comprehensive analytics for the USA, Canada, Japan, Europe and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2010. The report profiles 70 companies including many key and niche players worldwide such as Abbott Laboratories, ALTANA Pharma AG, AstraZeneca, Boehringer Ingelheim, Genentech, Inc., GlaxoSmithKline, Merck & Co., Inc., Novartis Pharma AG, Pfizer Inc., Schering-Plough Corporation and 3M. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Topics Covered

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

1. Market Overview

2. Trends & Issues

3. Product Overview

4. Product Launches/Innovations

5. Recent Industry Activity

6. Focus on Select Players

7. Global Market Perspective

II. MARKET

1. The United States

2. Canada

3. Japan

4. Europe

5. Rest of World

III. COMPETITION

Companies Mentioned

- 3M Company (USA) - Abbott Laboratories (USA) - Able Laboratories, Inc (USA) - Adams Respiratory Therapeutics (USA) - Aerovance, Inc (USA) - Almirall Prodesfarma SA (Spain)- Alpharma USPD, Inc (USA) - Altana Pharma AG (Germany) - Amgen, Inc (USA) - Asthmatx, Inc (USA) - Astrazeneca PLC (UK) - Biocon India Limited (India) - Boehringer Ingelheim GmbH (Germany) - Breckenridge Pharmaceutical, Inc (USA) - Cadila Pharmaceuticals Limited (India) - Cipla Ltd (India) - Coley Pharmaceutical Group, Inc (USA) - Cosmobio Co, Ltd (Japan) - Critical Therapeutics, Inc (USA) - deCODE Genetics (Iceland) - DMI BioSciences, Inc (USA) - Dr Reddys Laboratories (India) - Elan Corporation Plc (Ireland) - Epitomics, Inc (USA) - Eurodrug Laboratories Group (The Netherlands) - Exim Pharm International (India) - F Hoffmann-La Roche Ltd (Switzerland) - Forest Laboratories, Inc (USA) - Gilead Sciences (USA) - Glaxosmithkline PLC (UK) - Glenmark Pharmaceuticals Ltd (India) - GroPep Limited (Australia) - Indoco Remedies (India) - Inflazyme Pharmaceuticals Limited (Canada) - Janssen-Cilag GmbH (Austria) - Kos Pharmaceuticals, Inc (USA) - Kyorin Pharmaceutical Co, Ltd (Japan) - Lab International, Inc (Canada) - Lark Laboratories (India) - MAP Pharmaceuticals, Inc (USA) - Mayne Pharma Pty, Ltd (Australia) - MediciNova, Inc (USA) - Mercia Pharma, Inc (USA) - Merck KGaA (Germany) - Millennium Pharmaceuticals, Inc (USA) - MorphoSys AG (Germany) - Neurim Pharmaceuticals () Ltd (Israel) - Nicholas Piramal India Ltd (India) - Novartis AG (Switzerland) - Oriel Therapeutics, Inc (USA) - Pfizer, Inc (USA) - Pharmaxis Ltd (Australia) - Polyphor Limited (Switzerland) - Pure Pharma Limited (India) - Ranbaxy Laboratories Ltd (India) - Rigel Pharmaceuticals, Inc (USA) - Sanofi-Aventis (France) - Schering-Plough Corporation (USA) - Sepracor, Inc (USA) - Shinpoong Pharmaceutical Co, Ltd (South Korea) - SkyePharma PLC (UK) - Sumit Laboratories (India) - Surya Pharmaceutical Ltd (India) - Synairgen Research Limited (UK) - Tanabe Seiyaku Co, Ltd (Japan) - TEVA Pharmaceutical Industries Ltd (Israel) - Trudell Medical International (Canada) - UCB SA (Belgium) - Zedawn Formulations (P) Ltd (India) - Zenyth Therapeutics Limited (Australia)

For more information visit http://www.researchandmarkets.com/reports/c46170

Source: Business Wire

More News in this Category